Crescendo Biologics Appoints Matthew Roe as Chief Business Officer
24-Jun-2011
- United Kingdom
Crescendo Biologics Limited announced the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing.
During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company. He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme’s Pharmaceuticals business.
Other news from the department people
